Investigating how low-intensity ultrasound affects heart function
Investigation of Cardiac Function Following Low-Intensity Ultrasound Intervention
NA · ShanghaiTech University · NCT06567106
This study is testing whether low-intensity ultrasound can improve heart function and how it affects heart rhythms in participants.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 6 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | Male |
| Sponsor | ShanghaiTech University (other) |
| Locations | 1 site (Shanghai) |
| Trial ID | NCT06567106 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to explore the effects of low-intensity ultrasound on cardiac function by applying ultrasound to participants and monitoring their heart rhythms through electrocardiograms. The study will assess both the primary outcome of heart rhythm and secondary outcomes related to any treatment-related adverse events. All procedures are conducted in accordance with ethical standards and have received approval from the Research Ethics Committee of ShanghaiTech University.
Who should consider this trial
Good fit: Ideal candidates are healthy individuals aged 18 to 65 without significant diseases or chronic conditions.
Not a fit: Patients with existing heart disease or those with implanted electronic devices will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to new non-invasive methods for improving cardiac function.
How similar studies have performed: While the use of ultrasound in medical applications is well-established, the specific approach of this study is relatively novel and has not been extensively tested in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy individuals without significant diseases or chronic conditions. * Aged between 18 and 65 years. * Voluntary participation with signed informed consent. * No history of cardiovascular disease. Exclusion Criteria: * Individuals with heart disease or other conditions that may affect cardiac function measurement. * Individuals with implanted electronic devices such as pacemakers or defibrillators. * Those on medications that significantly alter heart rate, such as beta-blockers, unless under stable control for a specific period. * Individuals at risk of severe complications.
Where this trial is running
Shanghai
- Bingbing Cheng — Shanghai, China (RECRUITING)
Study contacts
- Study coordinator: Bingbing Cheng, Ph.D.
- Email: chengbb@shanghaitech.edu.cn
- Phone: +8620685173
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cardiac Function, Ultrasound, Heart, Cardiac function